Suchergebnisse - "ErbB Receptors immunology"

Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response

Autoren: Sabrina Sapski Nadine Beha Roland E. Kontermann et al.

Quelle: Cancer Immunol Immunother

Schlagwörter: 0301 basic medicine, 0303 health sciences, Recombinant Fusion Proteins, T-Lymphocytes, Tumor Escape/immunology [MeSH], Cell Line, Tumor [MeSH], Antibodies, Bispecific/immunology [MeSH], T-Lymphocytes/drug effects [MeSH], T-Lymphocytes/immunology [MeSH], Lymphocyte Activation/immunology [MeSH], Humans [MeSH], Tumor Microenvironment/drug effects [MeSH], Costimulation, Tumor Escape/drug effects [MeSH], Immunosuppression, Tumor Microenvironment/immunology [MeSH], Antibodies, Bispecific/pharmacology [MeSH], Antigens, Neoplasm/immunology [MeSH], Lymphocyte Activation/drug effects [MeSH], Original Article, Antibody-fusion proteins, ErbB Receptors/immunology [MeSH], Recombinant Fusion Proteins/immunology [MeSH], TNFSF ligands, Cancer immunotherapy, Bispecific antibody, Epithelial Cell Adhesion Molecule/immunology [MeSH], Recombinant Fusion Proteins/pharmacology [MeSH], Epithelial Cell Adhesion Molecule, Lymphocyte Activation, 3. Good health, ErbB Receptors, 03 medical and health sciences, Antigens, Neoplasm, Cell Line, Tumor, Antibodies, Bispecific, Tumor Microenvironment, Humans, Tumor Escape

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00262-020-02624-6.pdf
https://pubmed.ncbi.nlm.nih.gov/32504247
https://link.springer.com/article/10.1007/s00262-020-02624-6
https://link.springer.com/content/pdf/10.1007/s00262-020-02624-6.pdf
https://europepmc.org/article/MED/32504247
https://pubmed.ncbi.nlm.nih.gov/32504247/
https://www.ncbi.nlm.nih.gov/pubmed/32504247
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568714
https://repository.publisso.de/resource/frl:6470072

Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors.

Autoren: Ayeni, D. Miller, B. Kuhlmann, A. et al.

Schlagwörter: Animals, Antineoplastic Agents/therapeutic use, ErbB Receptors/genetics, ErbB Receptors/immunology, Erlotinib Hydrochloride/therapeutic use, Lung Neoplasms/drug therapy, Lung Neoplasms/genetics, Lung Neoplasms/immunology, Mice, Transgenic, Mutation, Oncogenes, Protein Kinase Inhibitors/therapeutic use, T-Lymphocytes/drug effects, T-Lymphocytes/immunology, Tumor Microenvironment/drug effects, Tumor Microenvironment/immunology, EGFR, Immunotherapies, Lung cancer, Mouse models, Targeted therapies

Dateibeschreibung: application/pdf

Relation: Journal for ImmunoTherapy of Cancer; https://iris.unil.ch/handle/iris/150720; serval:BIB_765E95D84B97; 000475646200001

Verfügbarkeit: https://iris.unil.ch/handle/iris/150720
https://doi.org/10.1186/s40425-019-0643-8

High Turnover of Tissue Factor Enables Efficient Intracellular Delivery of Antibody–Drug Conjugates

Autoren: Tong Zhu Paul W. H. I. Parren David Miao et al.

Weitere Verfasser: Tong Zhu Paul W. H. I. Parren David Miao et al.

Quelle: de Goeij, B E C G, Satijn, D, Freitag, C M, Wubbolts, R, Bleeker, W K, Khasanov, A, Zhu, T, Chen, G, Miao, D, van Berkel, P H C & Parren, P W H I 2015, ' High Turnover of Tissue Factor Enables Efficient Intracellular Delivery of Antibody-Drug Conjugates ', Molecular Cancer Therapeutics, vol. 14, no. 5, pp. 1130-1140 . https://doi.org/10.1158/1535-7163.MCT-14-0798

Schlagwörter: 0301 basic medicine, Receptor, ErbB-2, ErbB-2/immunology, Antineoplastic Agents, Apoptosis, Factor VIIa, Lysosomes/metabolism, Immunotoxins/administration & dosage, Antibodies, Cell Line, Mice, 03 medical and health sciences, ErbB Receptors/immunology, Drug Delivery Systems, SDG 3 - Good Health and Well-being, Neoplasms, Experimental/drug therapy, Neoplasms, Experimental/drug therapy, Cell Line, Tumor, Taverne, Animals, Humans, 2. Zero hunger, Tumor, Immunotoxins, GROWTH-FACTOR RECEPTOR FACTOR PATHWAY INHIBITOR FACTOR EXPRESSION FACTOR-VIIA TRASTUZUMAB EMTANSINE BREAST-CANCER MONOCLONAL-ANTIBODIES DOWN-REGULATION OVARIAN-CANCER CELLS, Neoplasms, Experimental, Xenograft Model Antitumor Assays, Antineoplastic Agents/administration & dosage, 3. Good health, Receptor, ErbB-2/immunology, ErbB Receptors, Factor VIIa/immunology, Lysosomes, Receptor

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/25724665
https://research-portal.uu.nl/en/publications/9173b47f-3ddc-40c6-bb0a-3423a8c24375
https://doi.org/10.1158/1535-7163.MCT-14-0798
http://mct.aacrjournals.org/content/molcanther/14/5/1130.full.pdf
https://www.narcis.nl/publication/RecordID/oai%3Ascholarlypublications.universiteitleiden.nl%3Aitem_2995735
https://mct.aacrjournals.org/content/early/2015/02/25/1535-7163.MCT-14-0798.abstract
https://europepmc.org/article/MED/25724665
https://mct.aacrjournals.org/content/molcanther/14/5/1130.full.pdf
http://dspace.library.uu.nl/handle/1874/330565
https://hdl.handle.net/1887/104001
https://portal.findresearcher.sdu.dk/da/publications/31f8abde-4a9b-4143-9238-ccf0b185ed17
https://dspace.library.uu.nl/handle/1874/330565

Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer

Autoren: Olsen, Dorte Aa Jakobsen, Erik H Brandslund, Ivan

Quelle: Olsen, D A, Jakobsen, E H & Brandslund, I 2013, ' Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer ', Clinical Chemistry and Laboratory Medicine, vol. 51, no. 12, pp. 2325-2329 . https://doi.org/10.1515/cclm-2013-0166

Schlagwörter: Adult, Receptor, ErbB-2, EGFR, Blotting, Western, Breast Neoplasms, Enzyme-Linked Immunosorbent Assay, ErbB2 gene amplification, 03 medical and health sciences, Breast cancer, ErbB Receptors/immunology, 0302 clinical medicine, Breast Neoplasms/blood, 80 and over, Humans, Aged, Autoantibodies, Aged, 80 and over, Blotting, Middle Aged, Receptor, ErbB-2/genetics, 3. Good health, ErbB Receptors, ELISA, Female, Autoantibodies/blood, Western, Receptor, ErbB-2/genetics

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/24021599
https://www.ncbi.nlm.nih.gov/pubmed/24021599
https://europepmc.org/article/MED/24021599
https://www.degruyter.com/view/j/cclm.2011.49.issue-5/cclm.2011.135/cclm.2011.135.xml
https://core.ac.uk/display/50691644
https://pubmed.ncbi.nlm.nih.gov/21320029/
https://portal.findresearcher.sdu.dk/da/publications/ef429d72-6abf-48a6-9a70-09dfcdb526da